Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Morbidity and mortality after heart transplanation].

M J Rebocho1, C Aguiar, J Queiroz e Melo

  • 1Serviço de Cirurgia Cardiotorácica, Hospital de Santa Cruz, Carnaxide, Portugal.

Revista Portuguesa De Cardiologia : Orgao Oficial Da Sociedade Portuguesa De Cardiologia = Portuguese Journal of Cardiology : an Official Journal of the Portuguese Society of Cardiology
|June 21, 2001
PubMed
Summary

Heart transplantation offers a valid treatment for end-stage heart failure, with most long-term survivors experiencing good quality of life. Key challenges include managing infection, rejection, and complications from immunosuppression.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Risks and benefits of sharing patient information on social media: a digital dilemma.

European heart journal. Digital health·2024
Same author

Electronic and structural properties of Möbius boron-nitride and carbon nanobelts.

Discover nano·2024
Same author

Möbius carbon nanobelts interacting with heavy metal nanoclusters.

Journal of molecular modeling·2023
Same author

ARNIs: balancing "the good and the bad" of neuroendocrine response to HF.

Clinical research in cardiology : official journal of the German Cardiac Society·2019
Same author

The role of tenofovir alafenamide in future HIV management.

HIV medicine·2016
Same author

Renal and cardiovascular risk predictive value of two different microalbuminuria screening methods in patients with hypertension with/without diabetes in Portugal.

Journal of human hypertension·2016

Area of Science:

  • Cardiology
  • Transplantation Medicine
  • Immunology

Background:

  • Heart transplantation is a critical intervention for end-stage heart failure.
  • Evaluating long-term outcomes is essential for refining patient care and management strategies.

Purpose of the Study:

  • To assess the morbidity and mortality rates following heart transplantation.
  • To analyze the causes of death and complications in patients undergoing heart transplantation at Santa Cruz Hospital.

Main Methods:

  • A retrospective analysis of 113 patients who underwent heart transplantation between February 1986 and December 2000.
  • Kaplan-Meier survival analysis was used to calculate survival rates at 12 months, 5 years, and 10 years.
  • Morbidity, causes of mortality, and quality of life (functional and employment status) were evaluated.

Related Experiment Videos

Main Results:

  • Actuarial survival rates were 82.2% at 12 months, 64.6% at 5 years, and 45.3% at 10 years, with a maximum survival of 14.7 years.
  • Infections were the leading cause of early mortality, while allograft vasculopathy and malignancy were major causes of late mortality.
  • Common morbidities included infections (35.4%), rejection episodes, tumors, allograft vasculopathy, and significant side effects of chronic immunosuppression such as hypertension (50%) and dyslipidemia (31%).

Conclusions:

  • Cardiac transplantation remains a viable treatment option for end-stage heart failure.
  • Long-term survivors generally achieve a good quality of life, comparable to the general population.
  • Ongoing monitoring for infection, rejection, and immunosuppression-related complications is crucial for optimizing patient outcomes.